Accruals

Cancer Trial Recruitment Activity in Ireland

This page provides figures relating to cancer clinical trial accruals in Ireland. Accruals refer to the number of patients recruited to cancer clinical trials.

The figures presented are for the full calendar year 2025. Comparative data from previous years is included where relevant.

While Cancer Trials Ireland makes every effort to capture recruitment data for all cancer trials active in Ireland, this is not possible in every instance. The figures below are therefore considered representative of more than 95% of cancer clinical trial recruitment activity nationally.

Recruitment figures are presented by disease area and include:

  • Interventional studies, including drug, radiotherapy, medical device, surgical, survivorship, diet and exercise trials
  • Non-interventional studies, including translational, observational and imaging studies, questionnaires, biobanks and registries

The portfolio includes both academic and industry-sponsored studies.

Please note: interpretation of accrual data requires an understanding of the clinical trials landscape in Ireland, including variations in study design, recruitment targets and portfolio composition. Readers outside the cancer trials community are advised not to interpret these figures in isolation and may contact Cancer Trials Ireland for further context or clarification.

Accrual by Disease Area (DSSG)

DSSG2025 202420232022
Basket*925924363226
Breast868642533520
CNS372500
GI3336114106
GU14519415287
Gynaecology2411149
Head & Neck1231634724
Lung**1,8462086445
Lymph & Haem611446263410
Melanoma641162722
Paeds147463420
Sarcoma76331
Total4,9262,8141,6141,470

* Basket trials include several different disease areas in one trial.
** 1757 patients are from the Lung Health Check Pilot

Accrual by Study Type

Study Type2025 Full Year
AI91
Allied Health & Supportive Care12
Bespoke 3D printed breast prosthesis30
Biobank101
Biomedical Cancer Research64
De-prescribing1
Imaging – Diagnostic low dose CT1,757
IMP358
IMP/IVDR26
IMP/MDR5
IMP/RT3
Machine learning3
Nutrition23
Observational533
Observational/Registry55
Physiotherapy95
Quality of life4
Questionnaire154
Registry186
RT169
Surgery/RT5
Surgical15
Survivorship83
Translational1,153
 4,926

Accrual by Trial Site

Site All Trials – 2025 Full Year  Interventional Non-Interventional
Beacon 49 10 39
Beaumont 2,319 36 2283**
BonS/UPMC 6 6 0
BSHC 26 12 14
CHI 147 52 95
CUH 191 59 132
MMUH/MPH 113 32 81
MRTH 21 0 21
MWROC 0 0 0
OLH&CS 150 0 150
SJH 136 61 75
SLRON 206 135 71
SUH 168 5 163
SVUH 439 77 362
TUH 58 30 28
UHG 443 164 279
UHG/RT 22 14 8
UHL 401 1 400
UHW 28 18 10
UPMC Whit 3 3 0
Total 4,926 715 4,211

** 1757 patients are from the Lung Health Check Pilot

Definitions

Interventional Trials:
Studies evaluating an intervention such as a drug, radiotherapy, surgical procedure, medical device, survivorship intervention, exercise programme or dietary intervention.

Non-Interventional Studies:
Studies that do not involve a therapeutic intervention. These include observational, translational and imaging studies, questionnaires, biobanks and registries.

All Trials:
Combined total of all interventional and non-interventional cancer clinical research activity included on this page.